Taisho Pharmaceutical Co Ltd.

TYO:4535 ISIN:JP3442800003

Taisho Pharmaceutical Co Ltd. (TSE: 4535) is Japan's leading producer of over-the-counter (OTC) drugs, and the number two OTC drug manufacturer in the world. Taisho is currently endeavoring to strengthen its independent R&D capabilities in the field of prescription pharmaceuticals, and also aggressively pursuing tie-ups with both Japanese and overseas companies. 
 
   

查看其它語言版本

新聞

大正製藥(TYO:4535)將以3.1億美元收購百時美施貴寶(NYSE:BMY)的亞洲資產

🕔9/16/2009 3:19:31 PM 5492

日本的大正製藥株式會社(TYO:4535)週三表示，將收購百時美施貴寶公司（Bristol-Myers Squibb Co.）(NYSE:BMY)在亞太地區（不包括中國和日本）價值3.1億美元的非處方藥業務。

閱讀全文▸
###

15,242 公司背景瀏覽

  • 本頁瀏覽人次: (過去7日: 6) (過去30日: 26) (自發布以來: 3449) 

公司詳細